Medical management of obstructive sleep apnea: a review article
DOI:
https://doi.org/10.18203/issn.2454-5929.ijohns20233594Keywords:
OSA, Medical management, CPAP, Myofunctional therapyAbstract
Obstructive sleep apnea (OSA) is characterized by repetitive episodes of complete or partial obstruction of upper airway during sleep. Various pathophysiological phenotypes contributing for the repetitive events of apnea and hypopnea have been identified in the recent studies. Consequently, various new modalities of treatment are being introduced to be implemented either independently or in conjunction with the previously available treatment modalities. This article imparts a thorough knowledge of various modes of treatment available for the non-surgical treatment of OSA. Many studies conducted in the past had emphasized the importance and effectiveness of lots of non-surgical modes of treating OSA. Our article includes a concluding description of all those studies including those on CPAP and myofunctional therapy. Thorough knowledge of both i.e., the pathophysiological phenotypes and available modes of treatment is necessary for the successful treatment of obstructive sleep apnoea. Recent advances, both in terms of causative factors as well as corresponding treatment options, should be laid down in the form of management guidelines as a part of evidence-based medicine.
Metrics
References
Borsoi L, Armeni P, Donin G, Costa F, Ferini-Strambi L. The invisible costs of obstructive sleep apnea (OSA): Systematic review and cost-of-illness analysis. PLoS One. 2022;17(5):e0268677.
Guilleminault C, Tilkian A, Dement WC. The sleep apnea syndromes. Annu Rev Med. 1976;27:465-84.
Punjabi NM, Caffo BS, Goodwin JL, Gottlieb DJ, Newman AB, O'Connor GT et al. Sleep-Disordered Breathing and Mortality: A Prospective Cohort Study. PLoS Med. 2009;6(8):e1000132.
Spicuzza L, Caruso D, Di Maria G. Obstructive sleep apnoea syndrome and its management. Ther Adv Chronic Dis. 2015;6(5):273-85.
Subramani Y, Singh M, Wong J, Kushida CA, Malhotra A, Chung F. Understanding Phenotypes of Obstructive Sleep Apnea: Applications in Anesthesia, Surgery, and Perioperative Medicine. Anesth Analg. 2017;124(1):179-91.
Cai Y, Tripuraneni P, Gulati A, Stephens EM, Nguyen DK, Durr ML et al. Patient-Defined Goals for Obstructive Sleep Apnea Treatment. Otolaryngol Head Neck Surg. 2022;167(4):791-8.
Pang KP, Rotenberg BW. The SLEEP GOAL as a success criterion in obstructive sleep apnea therapy. Eur Arch Otorhinolaryngol. 2016;273:1063-5.
Epstein LJ, Kristo D, Strollo PJ Jr, Friedman N, Malhotra A, Patil SP et al. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med. 2009;5(3):263-76.
Strohl KP, Brown DB, Collop N, George C, Grunstein R, Han F et al. An official American Thoracic Society Clinical Practice Guideline: sleep apnea, sleepiness, and driving risk in non-commercial drivers. An update of a 1994 Statement. Am J Respir Crit Care Med. 2013;187(11):1259-66.
Ward KL, Hillman DR, James A, Bremner AP, Simpson L, Cooper MN et al. Excessive daytime sleepiness increases the risk of motor vehicle crash in obstructive sleep apnea. J Clin Sleep Med. 2013;9(10):1013-21.
Newman AB, Foster G, Givelber R, Nieto FJ, Redline S, Young T. Progression and regression of sleep-disordered breathing with changes in weight: the Sleep Heart Health Study. Arch Intern Med. 2005;165(20):2408-13.
Davidson TM, Patel MR. Waist circumference and sleep disordered breathing. Laryngoscope. 2008;118(2):339-47.
Kuna ST, Reboussin DM, Strotmeyer ES, Millman RP, Zammit G, Walkup MP et al. Effects of Weight Loss on Obstructive Sleep Apnea Severity. Ten-Year Results of the Sleep AHEAD Study. Am J Respir Crit Care Med. 2021;203(2):221-9.
Edwards BA, Bristow C, O’Driscoll DM, Wong AM, Ghazi L, Davidson ZE et al. Assessing the impact of diet, exercise and the combination of the two as a treatment for OSA: a systematic review and meta-analysis. Respirology. 2019;24:740-51.
St-Onge MP, Tasali E. Weight Loss Is Integral to Obstructive Sleep Apnea Management. Ten-Year Follow-up in Sleep AHEAD. Am J Respir Crit Care Med. 2021;203(2):161-2.
Issa FG, Sullivan CE. Alcohol, snoring and sleep apnea. J Neurol Neurosurg Psychiatr. 1982;45(4):353-9.
Morgenthaler TI, Kapen S, Lee-Chiong T, Alessi C, Boehlecke B, Brown T et al. Practice parameters for the medical therapy of obstructive sleep apnea. Sleep. 2006;29(8):1031-5.
Van Maanen JP, de Vries N. Long-term effectiveness and compliance of positional therapy with the sleep position trainer in the treatment of positional obstructive sleep apnea syndrome. Sleep. 2014;37(7):1209-15.
Srijithesh PR, Aghoram R, Goel A, Dhanya J. Positional therapy for obstructive sleep apnoea. Cochrane Database Syst Rev. 2019;5(5):CD010990.
Camacho M, Malu OO, Kram YA, Nigam G, Riaz M, Song SA, Tolisano AM, Kushida CA. Nasal Dilators (Breathe Right Strips and NoZovent) for Snoring and OSA: A Systematic Review and Meta-Analysis. Pulm Med. 2016;2016:4841310.
Pavwoski P, Shelgikar AV. Treatment options for obstructive sleep apnea. Neurol Clin Pract. 2017;7(1):77-85.
Kushida CA, Morgenthaler TI, Littner MR, Alessi CA, Bailey D, Coleman J Jr et al. Practice parameters for the treatment of snoring and Obstructive Sleep Apnea with oral appliances: an update for 2005. Sleep. 2006;29(2):240-3.
Lim J, Lasserson TJ, Fleetham J, Wright J. Oral appliances for obstructive sleep apnoea. Cochrane Database Syst Rev. 2006;2006(1):CD004435.
Spicuzza L, Caruso D, Di Maria G. Obstructive sleep apnoea syndrome and its management. Ther Adv Chronic Dis. 2015;6(5):273-85.
Jordan AS, McSharry DG, Malhotra A. Adult obstructive sleep apnoea. Lancet. 2014;383(9918):736-47.
Owens RL, Malhotra A, Eckert DJ, White DP, Jordan AS. The influence of end-expiratory lung volume on measurements of pharyngeal collapsibility. J Appl Physiol. 2010;108(2):445-51.
Squier SB, Patil SP, Schneider H, Kirkness JP, Smith PL, Schwartz AR. Effect of end-expiratory lung volume on upper airway collapsibility in sleeping men and women. J Appl Physiol. 2010;109(4):977-85.
Patel SR, White DP, Malhotra A, Stanchina ML, Ayas NT. Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: results of a meta-analysis. Arch Intern Med. 2003;163(5):565-71.
Aloia MS, Ilniczky N, Di Dio P, Perlis ML, Greenblatt DW, Giles DE. Neuropsychological changes and treatment compliance in older adults with sleep apnea. J Psychosom Res. 2003;54(1):71-6.
Antonopoulos CN, Sergentanis TN, Daskalopoulou SS, Petridou ET. Nasal continuous positive airway pressure (nCPAP) treatment for obstructive sleep apnea, road traffic accidents and driving simulator performance: a meta-analysis. Sleep Med Rev. 2011;15(5):301-10.
Tregear S, Reston J, Schoelles K, Phillips B. Continuous positive airway pressure reduces risk of motor vehicle crash among drivers with obstructive sleep apnea: systematic review and meta-analysis. Sleep. 2010;33(10):1373-80.
Martínez-García M, Capote F, Campos-Rodríguez F. Effect of CPAP on Blood Pressure in Patients with Obstructive Sleep Apnea and Resistant Hypertension: The HIPARCO Randomized Clinical Trial. JAMA. 2013;310(22):2407-15.
Shirahama R, Tanigawa T, Ida Y. Long-term effect of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea. Sci Rep. 2021;11:19101.
Ruzicka M, Knoll G, Leenen FHH, Leech J, Aaron SD, Hiremath S. Effects of CPAP on Blood Pressure and Sympathetic Activity in Patients With Diabetes Mellitus, Chronic Kidney Disease, and Resistant Hypertension. CJC Open. 2020;2(4):258-64.
Logan AG, Tkacova R, Perlikowski SM, Leung RS, Tisler A, Floras JS et al. European Respiratory J. 2003;21(2):241-7.
Usui K, Bradley TD, Spaak J, Ryan CM, Kubo T, Kaneko Y et al. Inhibition of awake sympathetic nerve activity of heart failure patients with obstructive sleep apnea by nocturnal continuous positive airway pressure. J Am Coll Cardiol. 2005;45:2008-11.
Milleron O, Pillière R, Foucher A, de Roquefeuil F, Aegerter P, Jondeau G et al. Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study. Eur Heart J. 2004;25(9):728-34.
Chirinos JA, Gurubhagavatula I, Teff K, Rader DJ, Wadden TA, Townsend R et al. CPAP, weight loss, or both for obstructive sleep apnea. N Engl J Med. 2014;370(24):2265-75.
Nadeem R, Singh M, Nida M, Kwon S, Sajid H, Witkowski J et al. Effect of CPAP treatment for obstructive sleep apnea hypopnea syndrome on lipid profile: a meta-regression analysis. J Clin Sleep Med. 2014;10(12):1295-302.
Rotenberg BW, Murariu D, Pang KP. Trends in CPAP adherence over twenty years of data collection: a flattened curve. J Otolaryngol Head Neck Surg. 2016;45(1):43.
Ishak A, Ramsay M, Hart N, Steier J. BPAP is an effective second-line therapy for obese patients with OSA failing regular CPAP: A prospective observational cohort study. Respirology. 2020;25(4):443-8.
Schäfer H, Ewig S, Hasper E, Lüderitz B. Failure of CPAP therapy in obstructive sleep apnoea syndrome: predictive factors and treatment with bilevel-positive airway pressure. Respir Med. 1998;92(2):208-15.
Alves A, Gigante AR, Machado D, Sanches I, Marçoa R, Franco I et al. Transition from APAP to CPAP may be a cost-effective health intervention in OSA patients. J Bras Pneumol. 2021;47(6):e20210286.
Ayas NT, Patel SR, Malhotra A, Schulzer M, Malhotra M, Jung D et al. Auto-titrating versus standard continuous positive airway pressure for the treatment of obstructive sleep apnea: results of a meta-analysis. Sleep. 2004 Mar 15;27(2):249-53.
Sharma BK, Bakker JP, McSharry DG, Desai AS, Javaheri S, Malhotra A. Adaptive servoventilation for treatment of sleep-disordered breathing in heart failure: a systematic review and meta-analysis. Chest. 2012;142(5):1211-21.
Pepperell JC, Maskell NA, Jones DR, Langford-Wiley BA, Crosthwaite N, Stradling JR et al. A randomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure. Am J Respir Crit Care Med. 2003;168(9):1109-14.
Hakim TS, Bonnetti M, Bosco G, Camporesi EM. EPAP Devices Optipillows, Bongo Rx, and Theravent: Flow Resistance and The Pressures They Generate. J Sleep Med Disord. 2021;7(1):1119.
Freedman N. Improvements in current treatments and emerging therapies for adult obstructive sleep apnea. F1000Prime Rep. 2014;6:36.
Carley DW, Prasad B, Reid KJ, Malkani R, Attarian H, Abbott SM et al. Pharmacotherapy of Apnea by Cannabimimetic Enhancement, the PACE Clinical Trial: Effects of Dronabinol in Obstructive Sleep Apnea. Sleep. 2018;41(1):zsx184.
Ramar K, Rosen IM, Kirsch DB, Chervin RD, Carden KA, Aurora RN et al. American Academy of Sleep Medicine Board of Directors. Medical Cannabis and the Treatment of Obstructive Sleep Apnea: An American Academy of Sleep Medicine Position Statement. J Clin Sleep Med. 2018;14(4):679-81.
Hedner J, Stenlöf K, Zou D, Hoff E, Hansen C, Kuhn K et al. A Randomized Controlled Clinical Trial Exploring Safety and Tolerability of Sulthiame in Sleep Apnea. Am J Respir Crit Care Med. 2022;205(12):1461-9.
Schwartz JR. Modafinil in the treatment of excessive sleepiness. Drug Des Devel Ther. 2009;2:71-85.
Rosenberg R, Bogan R. Armodafinil in the treatment of excessive sleepiness. Nat Sci Sleep. 2010;2:95-105.
Brownell LG, West P, Sweatman P, Acres JC, Kryger MH. Protriptyline in obstructive sleep apnea: a double-blind trial. N Engl J Med. 1982;307(17):1037-42.
Douglas A. Hanzel, Nicholas G. Proia, David W. Hudgel. Response of Obstructive Sleep Apnea to Fluoxetine and Protriptyline. Chest. 1991;100(2)416-21.
Taranto-Montemurro L, Sands SA, Edwards BA, Azarbarzin A, Marques M, de Melo C et al. Desipramine improves upper airway collapsibility and reduces OSA severity in patients with minimal muscle compensation. Eur Respir J. 2016;48(5):1340-50.
Tan L, Furian M, Li T. Effect of acetazolamide on obstructive sleep apnoea in highlanders: protocol for a randomised, placebo-controlled, double-blinded crossover trial. BMJ Open. 2022;12:e057113.
Eskandari D, Zou D, Grote L, Hoff E, Hedner J. Acetazolamide reduces blood pressure and sleep-disordered breathing in patients with hypertension and obstructive sleep apnea: a randomized controlled trial. J Clin Sleep Med. 2018;14(3):309-17.
Taranto-Montemurro L, Messineo L, Azarbarzin A, Vena D, Hess LB, Calianese NA et al. Effects of the Combination of Atomoxetine and Oxybutynin on OSA Endotypic Traits. Chest. 2020;157(6):1626-36.
Taranto-Montemurro L, Messineo L, Sands SA, Azarbarzin A, Marques M, Edwards BA et al. The Combination of Atomoxetine and Oxybutynin Greatly Reduces Obstructive Sleep Apnea Severity. A Randomized, Placebo-controlled, Double-Blind Crossover Trial. Am J Respir Crit Care Med. 2019;199(10):1267-76.
Hu K, Li Q, Yang J, Hu S, Chen X. The effect of theophylline on sleep-disordered breathing in patients with stable chronic congestive heart failure. Chin Med J (Engl). 2003;116(11):1711-6.
Mulloy E, McNicholas WT. Theophylline in obstructive sleep apnea. A double-blind evaluation. Chest. 1992;101(3):753-7.
Kiely JL, Nolan P, McNicholas WT. Intranasal corticosteroid therapy for obstructive sleep apnoea in patients with co-existing rhinitis. Thorax. 2004;59(1):50-5.
Rezaeetalab F, Rezaeitalab F, Dehestani V. Inhaled steroids reduce apnea-hypopnea index in overlap syndrome. Pneumologia. 2013;62(4):212-4.
Kheirandish-Gozal L, Gozal D. Intranasal budesonide treatment for children with mild obstructive sleep apnea syndrome. Pediatrics 2008;122:e149-55.
Farid-Moayer M, Siegel LC, Black J. Oral pressure therapy for treatment of obstructive sleep apnea: clinical feasibility. Nat Sci Sleep. 2013;5:53-9.
Koka V, De Vito A, Roisman G, Petitjean M, Filograna Pignatelli GR, Padovani D et al. Orofacial Myofunctional Therapy in Obstructive Sleep Apnea Syndrome: A Pathophysiological Perspective. Medicina (Kaunas). 2021;57(4):323.
Camacho M, Certal V, Abdullatif J, Zaghi S, Ruoff CM, Capasso R et al. Myofunctional Therapy to Treat Obstructive Sleep Apnea: A Systematic Review and Meta-analysis. Sleep. 2015;38(5):669-75.
